Who are Aprexis's investors?

Aprexis's investors include CORI Innovation, Features Capital Holdings, FreshTracks Capital, Vermont Center for Emerging Technologies (VCET).

How much funding has Aprexis raised?

Aprexis has disclosed $721.5K raised across 1 round.

Where is Aprexis headquartered?

Aprexis is headquartered in Montpelier, US.

Aprexis

Montpelier, US · Founded 2024 · Vermont corporation · 4 known investors

Find your way into Aprexis

Paths you didn't know you had: your email and LinkedIn already hold routes to the Aprexis team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability. It serves pharmacists, health plans, and Medicaid/Medicare programs, with tools addressing medication adherence, health equity, and quality metrics such as HEDIS and Stars.

Digital Health Healthtech SaaS

Founders & leadership

MICHAEL HOWEExecutive

Board

ROBERT SQUIREBoard director

Investors · 4

CORI Innovationlisted by CORI InnovationHartland

Features Capital Holdingslisted by Features Capital HoldingsLebanon

How we know: Features Capital Holdings's portfolio page · Not right? Tell us

FreshTracks Capitallisted by FreshTracks CapitalShelburne · $600K – $2Mvia Lee Bouyea · led

How we know: FreshTracks Capital's portfolio page · Not right? Tell us

Vermont Center for Emerging Technologies (VCET)listed by Vermont Center for Emerging Technologies (VCET)Burlington · $25K – $250K

How we know: Vermont Center for Emerging Technologies (VCET)'s portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$721.5K disclosed across 1 round · 2023

▶$721.5KraisedOct 2024 · 9 investors · Health Insurance

Rule 506(b)

Officers, directors & promoters on the filing

MICHAEL HOWEExecutive Officer
ROBERT SQUIREDirector

Offering amount: $1.5M
Amount sold: $721.5K
Minimum investment: $10K
Proceeds to insiders: $150K
First sale: Sep 2023
Incorporated: Corporation, Vermont, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Elion

Redsail TechnologiesRedSail Technologies provides pharmacy management systems and integrated pharmacy solutions serving health systems and pharmacy operations across the United States. The company delivers software, automation, and clinical programs to optimize medication management and patient care outcomes in healthcare settings.

PointclickcarePointClickCare provides a cloud-based healthcare software platform with AI-driven tools for care coordination, point-of-care documentation, medication management, and predictive analytics. It serves providers, payers, health plans, hospitals, and ACOs across the long-term and post-acute care and value-based care landscape.

ProxsysRxProxsysRx builds and operates on-site outpatient retail pharmacies for hospital systems and manages 340B drug pricing programs, PBM alignment, readmission reduction, and patient financial assistance. It serves hospitals and health systems, providing pharmacy operations, analytics, and compliance reporting at no direct cost to the hospital.

RIS RxRIS builds a pharmacist-driven platform for pharmaceutical manufacturers to detect and prevent gross-to-net (GTN) revenue leakage, copay misuse, and fraud through real-time claim adjudication and audits. It offers copay program management and reimbursement tools aimed at protecting drug-brand revenue while keeping patients on therapy.

Companies working in the same space as Aprexis.

Frequently asked questions

What does Aprexis do?: Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability. It serves pharmacists, health plans, and Medicaid/Medicare programs, with tools addressing medication adherence, health equity, and quality metrics such as HEDIS and Stars.
Who are Aprexis's investors?: Aprexis's investors include CORI Innovation, Features Capital Holdings, FreshTracks Capital, Vermont Center for Emerging Technologies (VCET).
How much funding has Aprexis raised?: Aprexis has disclosed $721.5K raised across 1 round.
Where is Aprexis headquartered?: Aprexis is headquartered in Montpelier, US.